Christer Tannergren

ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO

Niclas Petri, Christer Tannergren, Birgit Holst et al. · Drug Metabolism and Disposition · 2003 · 221 citations

Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique

Åsa Sjöberg, Mareike Lutz, Christer Tannergren et al. · European Journal of Pharmaceutical Sciences · 2012 · 215 citations

Comprehensive Study, Ussing Chamber Technique, Gastrointestinal Pharmacology +10

In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim

Erik Sjögren, Jan Westergren, Iain Grant et al. · European Journal of Pharmaceutical Sciences · 2013 · 167 citations

Gastrointestinal Drug Absorption, Gastrointestinal Pharmacology, Medicine +11

Toward an Increased Understanding of the Barriers to Colonic Drug Absorption in Humans: Implications for Early Controlled Release Candidate Assessment

Christer Tannergren, A. Bergendal, Hans Lennernäs et al. · Molecular Pharmaceutics · 2009 · 139 citations

Substance Abuse, Cytochrome P450 3A, Permeability Markers +13

Transport Characteristics of Fexofenadine in the Caco-2 Cell Model

Niclas Petri, Christer Tannergren, David Rungstad et al. · Pharmaceutical Research · 2004 · 129 citations · Full text

Biophysical Modeling, Membrane Transport, Transport Phenomena +5